Detail akcie Malin Corp online

Business Summary: Malin Corporation plc is an Ireland-based global life sciences company. The Company's businesses include 3D4Medical, which is a technology company; Altan, which is an injectable drug company; AN2H Discovery Limited, which focuses on designing novel small molecule therapeutics; Emba Medical Limited, which offers vascular embolization system; Emba Neuro Limited; Hatteras Venture Partners (HVP), which is a life sciences company; Immunocore, which is a biotechnology company; Jaan Health, which is a healthcare mobile technology company; Kymab Limited, which is a biopharmaceutical company; Melinta Therapeutics, Inc.; Novan, Inc., which is a clinical stage company; Poseida Therapeutics, Inc., which is a human therapeutics company, and Viamet Pharmaceuticals, Inc., which is a drug discovery company. The Company operates through subsidiaries, and focuses on various therapeutic areas, including dermatology, anti-infective, pain, immunology, oncology, neurology, anatomy and other areas.
Financial Summary: BRIEF: For the six months ended 30 June 2018, Malin Corporation plc revenues increased 4% to EUR22.5M. Net loss decreased 16% to EUR22.5M. Revenues reflect Rest of world segment increase from EUR1.8M to EUR5.3M, Spain segment increase of 4% to EUR12.4M. Lower net loss reflects Equity Earnings -Before increase from EUR5.6M (expense) to EUR7.5M (income), Equity Earnings -Before Taxes decrease of 91% to EUR1.2M (expense).